Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis

Published:2018-10-19 Issue:3 Volume:38 Page:727-738
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Yu Chen,Jin Shangyi,Wang Yanhong,Jiang Nan,Wu Chanyuan,Wang Qian,Tian Xinping,Li Mengtao,Zeng Xiaofeng

Funder

The Chinese National Key Technology R&D Program

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4340-7/fulltext.html

Reference45 articles.

1. Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038

2. Smolen JS, Landewe R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977

3. Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, Shuren J, Temple R, Woodcock J, Yue LQ, Califf RM (2016) Real-world evidence - what is it and what can it tell us? N Engl J Med 375(23):2293–2297

4. Hyrich KL, Watson KD, Lunt M, Symmons DP, British Society for Rheumatology Biologics R (2011) Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008. Rheumatology (Oxford) 50(1):117–123

5. Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J, Thorne JC, Tin D, Keystone EC, Bykerk V, for the CATCH Investigators, Ahluwalia V, Akhavan P, Arbillaga H, Baron M, Bell M, Bensen W, Boire G, Bykerk V, Cividino A, Colmegna I, Haraoui P, Hitchon C, Jamal S, Keystone E, Klinkhoff A, Kraishi M, Larche M, Lyddell C, Menard H, Mosher D, Nair B, Norris E, Penney C, Pope J, Rubin L, Shaw E, Sutton E, Thorne JC, Zummer M (2014) Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH). J Rheumatol 41(11):2161–2166

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and prevalence of clinical remission of rheumatoid arthritis in a nationwide study from Indonesia;International Journal of Rheumatic Diseases;2024-02

2. Terapéutica farmacológica actual para artritis reumatoide, factores para su eficacia y complicaciones asociadas: revisión sistemática;Interdisciplinary Rehabilitation / Rehabilitacion Interdisciplinaria;2024-01-15

3. Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2);Modern Rheumatology;2023-12-07

4. Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib;Journal of Clinical Medicine;2023-10-23

5. The perspective of Polish patients with rheumatoid arthritis – treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study);Rheumatology;2023-10-06